Lowã¢â‚¬âcalorie Sweeteners and Other Sugar Substitutes a Review of the Safety Issues Manfred Kroger

• Journal List
• J Food Sci Technol
• 5.51(4); 2014 April
• PMC3982014

J Food Sci Technol. 2014 Apr; 51(4): 611–621.

Artificial sweeteners – a review

Sanchari Chattopadhyay

Department of Food Engineering and Biochemical Engineering, Jadavpur University, Kolkata, 700032 India

Utpal Raychaudhuri

Department of Food Technology and Biochemical Engineering, Jadavpur Academy, Kolkata, 700032 Republic of india

Runu Chakraborty

Department of Food Applied science and Biochemical Engineering, Jadavpur Academy, Kolkata, 700032 India

Revised 2011 Sep seven; Accepted 2011 Oct 10.

Abstruse

At present a days sugar costless food are very much popular because of their less calorie content. So food industry uses various artificial sweeteners which are low in calorie content instead of high calorie carbohydrate. U.S. Nutrient and Drug Assistants has canonical aspartame, acesulfame-k, neotame, cyclamate and alitame for employ as per acceptable daily intake (ADI) value. But till date, breakdown products of these sweeteners have controversial health and metabolic effects. On the other hand, rare sugars are monosaccharides and have no known health furnishings because information technology does not metabolize in our body, but shows same sweetness taste and majority property every bit carbohydrate. Rare sugars accept no such ADI value and are mainly produced by using bioreactor and so inspite of high demand, rare sugars cannot exist produced in the desired quantities.

Keywords: D-allose, D-psicose, Low calorie sweetener, Stevia, Carbohydrate alcohols

Introduction

Obesity is a major problem throughout the world. Surveys consistently prove that people are concerned by weight and its health related implications, and for that most individuals are making a concerted effort to either maintain or lose weight. (Serdula et al. 1999; Scott et al. 2006).

Today the major goal of diabetes management is control of blood glucose. So the consumers have a free choice of food products. They must cull the correct food to comply with dietary recommendations and at the aforementioned time the food industry tin can considerably contribute to this change past providing adjusted nutrient products. This led food industry to discover several forms of alternative intense sweeteners, which take made possible to offer consumer the sweet gustatory modality without the calories.

Sugar cannot simply be replaced by these type of intense sweetener because the question of bulk, quality, intensity of sweetness and physical characteristics. Due to these features, rare sugars are desirable for depression calorie, equally well as bulk sweetener. These sugars tend to have desirable sugariness but are not metabolized in the homo body and therefore do non provide calorie intake.

Artificial sweetener

The sensory properties of nutrient is highly influenced by the sensory properties like sense of taste odour texture and advent (Sorensen et al. 2003). The selection and consumption of food in homo play a crucial part in the regulation of human appetite and nutrient intake. A sweetener is a nutrient additive, which mimics the event of sugar on taste. Therefore, they are called sugar substitutes. Consumers oft select those foods, which are composed of depression calorie sweetener because they want the taste of sweet without added calories. The dietary option that such product provides may be especially helpful in the management of obesity or diabetes mellitus.

One group of such sweeteners consists of substances with a very intense sugariness taste and is used in minor amount to supercede the sweetness of a much higher amount of sugar. The sweeteners of this blazon currently approved for apply in the United States are- Aspartame, Acesulfane-M, Neotame, Saccharin, Sucralose, Cyclamate and Alitame. Table1 summarizes some information about high intensity sweeteners (Godshall 2007).

Tabular array i

Properties of high intensity sweeteners*

Sweetener	Other Names	Sweetness**	Comments
Acesulfame Yard	Ace K; Sunette; Sweetness & Safe; SweetOne	200	N-sulfonyl amide structure; approved 2003.
Alitame	–	2000	Aspartame amide analog (GRAS pending since 1986); limited blessing in iv countries (United mexican states, Australia, New Zealand, China)
Aspartame	NutraSweet; Equal	180–200	Aspartyl-phenylalanine methyl ester; approved 1981 .
Cyclamate	Sucaryl, Sugar Twin	30–50	Sulfamic acid Na or Ca salt; approved in 50 countries; not Us
Neotame	–	7,000–13,000 Avg 8,000	Derivative of aspartame, more stable than aspartame; approved 2002
Saccharin	Sugariness'n' Low	300	N-sulfonyl amide structure; the get-go low-cal sweetener
Sucralose	Splenda	600	Trichlorinated derivative of sucrose; approved 1998.

Aspartame

Aspartame (Fig.1a) was discovered in 1965 by James Schlatter a chemist (Mazur et al. 1970). It is an artificial, not-saccharide sweetener, L-aspertyl-L phenylalanine methyl ester that is a methyl ester of the dipeptide of the amino acids aspartic acrid and phenylalanine. Under strongly acidic or alkaline weather, aspartame may generate methanol past hydrolysis. Nether more astringent conditions, the peptide bonds are also hydrolyzed, resulting in the free amino acids. It is slightly soluble in water, (about 3gm per 100ml, pH iii at room temp.). The solubility increases with higher or lower pH also every bit with increased temperature. In aqueous solution the relationship between pH and stability of aspartame is a bell-shaped curve with the maximum stability at pH iv.three (Mazur and Ripper 1979).

Chemic structure of low calorie Sweeteners

This sweetener is marketed under a number of trademark names including Equal, Nutrasweet, and Candere and has a good clean sweet taste but its time-intensity profile differs from sucrose.

Synthesis

Chemical synthesis of aspartame involves the coupling of the two amino acid units having appropriate functional group protection with conventional synthetic reagents. The two major processes are known equally the Z- and F- processes named after the protecting group used on the aspartyl group. Both of these processes produce some β-coupled products together with the desired α-aspartame.

The Z-procedure mainly involves the dehydration of the benzyloxycarbonyl-L-aspartic acid with acetic anhydride. The anhydride is then coupled with the methyl ester of Fifty-phenylalanine in toluene to give a mixture of benzyloxy carbonyl α-and β aspartames. The protecting groups are removed past hydrogenolysis and resulting mixture of aspartame isomer yield aspartame upon crystallization (Ager et al. 1998).

The F-process involves the protection of the amino group of aspartic acid with a formyl group and concomitant dehydration to form anhydride. The anhydride is and so coupled either with L-phynylalanine or its methyl ester (Loma et al. 1991) and the formyl grouping removed by acrid hydrolysis. The resultant mixture of α and β products are subjected to the esterification conditions of aqueous methanol and preferentially crystallizes out from this mixture and is so neutralized to yield aspartame.

The application of biotechnology and biocatalysts towards the synthesis of the aspartame has been extensively explored. Due to the presence of its dipeptide construction many variations of reverse proteolysis that employ both kinetically and thermodynamically controlled approaches has been investigated with different enzymes and under various reaction status. Two Japanese companies have reported i formation road to produce aspartame directly by incubating microorganisms with L- aspartic acid and methyl ester of phenylalanine (Ager et al. 1998).

Metabolism and health aspect

Aspartame is a depression calorie sweetener used to sweeten a variety of low and reduced calorie foods and beverages including low calorie tabletop sweetener every bit well as for use in gum, breakfast cereal and other dry products.

Aspartame provides free energy of 4 calories per gram. Aspartame is unstable if subjected to prolong heating and therefore cannot be used in baking or cooking. It also decomposes in liquids during storage.

Upon ingestion, aspartame breaks downwards into natural residual components, including aspartic acrid, phenylalanine, methanol and further break downward products including formaldehyde, formic acrid and diketopiperazine (George et al. 2010; Trocho et al. 1998). Each of which then metabolized just every bit information technology would be if derived from other dietary sources and are rubber every bit consumed in normal diets.

Aspartame has been the subject of controversy regarding its safety since its initial blessing past the U.S. Nutrient and Drug Administration (FDA) in 1974 (Magnuson et al. 2007).

High level of the naturally occurring essential amino acid phenylalanine is a wellness risk to those born with phenylketonuria (PKU) a rare inherited disease. Then the phenylalanine level statement or aspartame—sweeten products is for their benefit and has no relevance for general population. Various scientific researches concluded that the effects of aspartame are probable to be attributable to methanol or its metabolites, evidence indicating that fruits and vegetables too contain high level of methanol than aspartame sweetened food and drinkable do. But loftier intake of fruits and vegetables are associated with decrease rather than increase in cancer run a risk (Heber 2004). Carcinogenicity studies of aspartame were conducted by Nalt Toxicological Programme (NTP) in 2 strains of transgenic mice, and it was concluded that aspartame exposure was associated with increment in cancer in either male or female mice (NTP 2005). Based on government enquiry reviews and recommendations from advisory bodies such as European Commissions Scientific Committee on Food and articulation FAO/WHO expert committee on food additives, aspartame has been found to be safe for homo consumption by more than than xc countries worldwide (Magnuson et al. 2007).

Acesulfame—k

Acesulfame—k (Fig.1b) has been adult as sweetener past Hoechst (Clauss and Jensen 1970). This high intensity sweetener is potassium salt of 6-methyl-123-axathiazine-4(3H)-ane ii,2-dioxide with molecular formulaC₄H₄KNO_ivS and molecular weight of 201.24. It is a white crystalline pulverization, approximately 120 times sweeter than sucrose and has high water solubility (Rymon Lipinski 1991).

Acesulfame—k is oestrus stable, so can be used in cooking and blistering (Nabors 2002). It may have a bitter after taste when used lonely to sweeten food or beverage (Horne et al. 2002) Ace-grand is often blended with other sweetener (ordinarily sucralose or aspartame) whereby each sweetener masks the other's afterward gustatory modality and exhibit a synergistic furnishings by which the blend is sweeter than its components.

Synthesis

Early methods for Ace-k synthesis used chlorosulfonyl or flurosulfonyl isocyanate with propyne acetone (Clauss and Jensen 1970) and with other chemicals give N-chloro or Northward-(fluro-sulfonyle) acetoacetamide, which is then cyclized past metabolic potassium hydroxide to requite Ace-thou. Alternative method involves the treatment of acetoacetamide with at least 2 equivalents of sulfur trioxide. This results in formation of Due north-sulfoacetoacetamide, which is so dehydrated by sulfur trioxide to grade oxathiaazinone dioxide. Neutralization with potassium hydroxide gives Ace-thou. (Clauss et al. 1993).

Metabolism and health attribute

Acesulfame—k is not metabolized in the human body, thus it provides no calories and does not influence potassium intake despite its potassium content (ADA 2004). In 1988 USFDA approved the utilise of Ace-k in a diverseness of dry food products and in alcoholic beverages. In 2003 the agency approved its use as a full general-purpose sweetener (USFDA 2003). I breakup product of ace-k is acetoacetamide (George et al. 2010) known to be toxic if consumed in very large doses because human exposure to this breakdown product would be negligible. The USFDA concluded that no further testing of it was necessary.

Sucralose

Sucralose (Fig.1c) was discovered in 1976. This non-nutritive sweetener is made from sucrose by a process that substitutes 3 chloride atoms for 3 hydroxyl groups on the sucrose molecule (FDA 2006). Sucralose is 450–650 times sweeter than sucrose, has a pleasant sweet taste and its quality and time intensity profile is very close to that of sucrose (Arora et al. 2009). It has a moderate synergy with other nutritive and non-nutritive sweeteners. (Beyts et al. 1995).

Information technology is very much soluble in water and is stable over a wide range of pH and temperature. It does liberate HCl when stored at high temperature and produce some kind of discoloration (Beyts et al. 1995).

Synthesis

The synthesis of sucralose involves a series of selective protection and deprotection steps so that the 4-hydroxyl group tin can exist converted to a chloro atom with inversion of configuration. Handling of the free hydroxyl groups with sulfuryl chloride produce trichlorodisaccharide which is then deprotected to give the sucralose (Ager et al. 1998). The employ of enzymes or microbial cultures to augment constructed organic chemistry and carry our selected functionalization of complex molecule has been widely documented in the growing field of biocatalysis (Wong and Whitesides 1994).

Metabolism and health aspect

Although sucralose is made from sugar, the human torso does not recognize information technology as a sugar and does non metabolize it therefore information technology provides no calories. The bulk of sucralose ingested does non exit the gastrointestinal tract and is directly excreted in the feces while xi–27% of information technology is absorbed (Knight 1993). The amount that is absorbed from the gastro abdominal tract is largely removed from the blood stream by the kidneys and eliminated in the urine. As information technology is an organo chloride and some of which are known to have significant toxicity (Patel et al. 2006) but sucralose is not known to be toxic. In addition sucralose does not breakdown or dechlorinate. In determining the safety of sucralose, the FDA reviewed information from more than 110 studies in human and animals. Many of the studies were designed to identify possible toxic effects including carcinogenic reproductive and neurological effects simply no such furnishings were plant. Food and Drug Administration (FDA) approval is based on the findings that sucralose is safe for human consumption. U.S. Food and Drug Administration (USFDA) approved sucralose equally a general-purpose sweetener. The acceptable daily intake (ADI) for sucralose in US is 5mg/kg body weight/day. The estimated daily intake for percentile consumers as calculated by USFDA is i.6mg/kg body weight/solar day (USFDA 1999).

Saccharin

Saccharin (Fig.1d) was discovered by Remson and Fahlberg in 1878 at the Johns Hopkings Academy, Baltimore. It is a non-nutritive sweetener of ane,2-benzoisothiazol-3-(2H) on i,i dioxide. Saccharin has an unpleasant bitter or metallic off gustation. As the parent compound is only sparingly soluble in h2o, the sweetener is unremarkably used every bit the sodium or calcium salt. Both salts are highly water soluble, 0.67 gms/ml.of water at room temperature (Priebem and Kauffman 1980). It is about 300 times sweeter than sucrose.

Synthesis

Chemical synthesis of saccharin involves the oxidation of the o-toluenesulfonamide with variety of agents similar potassium permanganate (Tarbell and Tarbell 1978), chromic acid, electrochemically (Bennett et al. 1992) etc. to the corresponding carboxylic acid. The ortho isomer is dehydrated to requite the sweetener. (Bennett et al. 1992; Drasar et al. 1972). Some other process involves diazotization of methyl anthranilate and then handling of the diazonium table salt with sulfur dioxide and chloride gas to give the sulfonyl chloride which is then treated with ammonia to give saccharin (Tarbell and Tarbell 1978).

Metabolism and health aspect

The FDA tried to ban saccharin in 1977 considering animal studies had showed that information technology caused cancer in rat (mainly bladder cancer). Many studies have since been performed on saccharin. No study has e'er shown a clear casual relationship between saccharin consumption and health risks in human at normal doses. Though some studies have shown a correlation between consumption and cancer incidence (Weihrauch and Diehl 2004). Saccharin is currently permitted for employ under an interim regulation that specifies the amounts of saccharin permitted in beverages, processed food, and sugar substitute and requires that the production level must state saccharin in the ingredient declaration and specify the corporeality used (Kroger et al. 2006).

Cyclamate

Cyclamate (Fig.1e) was discovered in 1937. Information technology was used as a low calorie sweetener in the U.s.a. in 1950s and 1960s. It is a salt of cyclohexylsulfamic acid. Sodium cyclamate is used as non- nutritive sweetener and the analogous calcium table salt used specially in low sodium diets. Cyclamate is 30 times sweeter than sucrose. Information technology has a bitter off taste, just has good sweetness synergy with saccharin. It is soluble in water and its solubility can be increased past preparing the sodium or calcium salt (Bopp et al. 1986).

Synthesis

This process begins with the trisaccharide raffinose followed by chemic chlorination to form tetrachloro raffinose TCR. This TCR is and then enzymatically treated with a galactosidase to motility the 6-chloro-six-deoxygalactosyl moieties from the 6th position to yield cyclamate (Bennett et al. 1992). There are another two methods available for synthesis of saccharin like bioorganic synthesis (Drasar et al. 1972) and regioselective deacylation.

Metabolism and wellness aspect

Cyclamate itself shows very low toxicity but is metabolized by the gut leaner to cyclohexylamine which shows greater toxicity (Bopp et al. 1986) because of the nature of cyclamate metabolism. Information technology would exist inappropriate to assume that the total daily intake of cyclamate is metabolized to cyclohexylamine. The acceptable daily intake (ADI) for cyclamate was calculated by both the scientific committee of food (SCF) and the joint adept committee on food additives (JECFA) based on the "no observed adverse outcome level" (NOAEL). For cyclohexylamine in rats bold that 18.9% of the daily intake of cyclamate is metabolized to cyclohexylamine each 24-hour interval (SCF 2000). The plasma concentrations of cyclohexylamine following cyclamate intake will depend on both the extent of metabolism by the intestinal flora and the extent of elimination of cyclohexylamine from the circulation.

Scientific enquiry on cyclamate is continuing. Contempo studies accept provided new data on the extent to which individuals convert cyclamate to cyclohexylamine during long term consumption (Renwick et al. 2004). This study gives starting time truthful indication of possible exposure to cyclohexylamine from cyclamate metabolism in humans over a menstruation that is toxicologically relevant to the institution of ADI for cyclamate.

Neotame

Neotame (Fig.1f) is a derivative of a dipeptide compound of the amino acids - aspertic acrid and phenylalanine. Neotame has been developed as a sweetener with a high degree of sweetness and is obtained by Due north-alkylating aspartame. Its degree of sugariness varies according to the kind of food and blend limerick. It is 7000 to 13,000 times and about 30 to 60 times sweeter than sugar and aspartame respectively (Prakash et al. 2002).

Neotame is an odorless white to grey-white powder with a stiff sweetness and is readily soluble in alcohols and slightly soluble in h2o. The 0.5% aqueous solution of neotame is weakly acidic (pH 5.viii) (Prakash et al. 2002).

Synthesis

A chemoenzymatic method used for preparing Northward-[N-(3-3dimethylbutyl)-L-a aspertyl]-L-phenylamine one- methyl ester via the enzymatic regioselective hydrolysis of neotame ester using lipases or estarages (Prakash and Zhao 2001).

Another method involve the hydrogenation of 50-α-aspartyl –L- phenylalanine I methyl ester and iii–iii dimethylbutyraldehyde produced insitu by the hydrolysis or cleavage of a three-three-dimethylbutyraldehyde precursor (Prakash 2007).

Metabolism and health aspect

Neotame is rapidly metabolized, completely eliminated and does not accumulate in the torso. The major metabolic pathway of neotame is hydrolysis of the methyl ester by esterase which is present throughout the torso. This yields deesterified neotame, the major metabolite and a meaning corporeality of methanol. Due to the presence of the three-3-di-methylbutyl group, peptidases which would typically pause the peptide bond between the aspartic acrid and phenylalanine moieties are essentially blocked, thus reducing the availability of phenylalanine. The amount of methanol derived from neotame is exceedingly small (Neotame 2002). Neotame was canonical by the USFDA as a full general purpose sweetener in July 2002 (USFDA 2002). Information technology has also been favorably evaluated by JECFA (JFECFA 2004) which established an ADI of 2mg/kg body weight/day. The ADI for neotame in the US is eighteen mg/person/day (USFDA 2002).

Alitame

Alitame (Fig.1g) is an intense sweetener with sweetness potency 200 times greater than that of sucrose. It is a dipeptide of L-aspartic acrid and D-alanine with a terminal N-substituted tetra methylthietanyl-amine moiety.

Synthesis

Alitame is prepared past a multi stride synthesis involving the reaction between ii intermediates (S)-[2-5-dioxo-(4-thiazolidine)] acerb acrid and (R) –2- amino-N-(2,2,4-four-tetramethyl-3-thietanyl) propanamides. The last production is isolated and purified by crystallization of an alitame −4-methylbenzenesulfonic acid adduct followed by additional purification steps and finally recrystallization from water (Peter et al. 2002).

Metabolism and health aspect

Alitame is readily absorbed in the GI tract so quickly metabolized and excreted. Information technology has 2 chief components, aspartic acid and alanine amide. The aspartic acid component is metabolized normally and the alanine amide passes through the body with minimal metabolic changes. In humans the glucoronic derivative of D-alanine tetramethylthietane amide is the major urinary metabolite. JEFCA reviewed safety data on alitame in 2002. The committee concluded that in that location was no evidence that alitame is carcinogenic. An ADI of 0–one mg/kg body weight was allocated on the basis of the NOAEL of 100mg/kg trunk weight/day to an 18 month study in dogs. Alitame has already been approved in United mexican states, Colombia and People's republic of china besides as Australia and New Zealand (Kroger et al. 2006).

Rare sugar

Rare sugars, which are defined as monosaccharides and their derivatives that are rare in nature (Izumori 2002) have recently attracted a swell bargain of attention mainly apropos their awarding. This could provide an culling to the other sweetener due to its lack of calories. Rare sugars are either not metabolized by the trunk or metabolized to a lesser extent than natural carbohydrate. Due to these features, rare sugars are well tolerated by diabetes patients. Other advantage of rare sugar is the absence of any objectionable after gustation (Zakaria 2001).

D-psicose

D-psicose (Fig.1h) (D-ribo-2 hexulose), a C-3 epimer of D-fructose is a rare sugar present in small quantities in commercial mixtures of D-glucose and D-fructose obtained from the hydrolysis of sucrose or isomerization of D-glucose (Light-green and Perlin 1968). D-psicose has 70% of the sweet of sucrose and has a higher solubility that makes it easy to use for food processing.

It has been reported that the improver of D-psicose in food products improve the gelling behavior and flavor besides as it increases the antioxidant property of the food products (Sun et al. 2006; Lord's day et al. 2007). Furthermore, food products containing D-psicose maintain a high level of antioxidant effect over a long menses of storage, which is able to filibuster the onset of lipid car-oxidation and extend the food storage time (Lord's day et al. 2008). It gives proper sweetness, smooth texture, desirable mouthfeel and great self-stability to food products.

Synthesis

D-psicose has previously been produced by chemic methods from D-fructose using catalytic activity of molybdate ions in an acidic aqueous solution (Bilik and Tihlarik 1973) it is also sometimes prepared past humid D-fructose in ethanol and triethylamine (Doner 1979). All the chemic methods are insufficient in terms of large-scale production.

An improved process for the mass production of D-psicose was adult using D-tagatose −3 epimerase bioreactor. D fructose solution (60%, pH 7.0) was passed at 45°C through a column filled with immobilized D-tagatose-3-epimerage (D-TE) which was produced using recombinant E.Coli. and 25% of the substrate was converted to D-psicose. Subsequently epimerization, the substrate D-fructose was removed past treatment with bakery's yeast. The supernatant was concentrated to syrup by evaporation under vacuum and D-psicose was crystallized with ethanol (Takeshita et al. 2002).

Some other work was done for mass production of D-psicose using a non characterized factor from Agrobacterium tumifaciens which increase the production 586 fold higher than that of D-TE. The enzyme is D-psicose-iii-epimerase. This finding has considerable importance in D-psicose production (Kim et al. 2006).

Metabolism and health attribute

An animate being report on the suppression of increment in plasma glucose concentration with D-psicose institute pregnant driblet in plasma glucose concentration when maltose and sucrose were used as substrates, but no significant drop when glucose and soluble starch were used as substrate (Matsuo 2006). Another animal study proposed that D-psicose inhibited the hydrolysis of maltose with α-glucosidase in rats (Matsuo and Izumori 2006). The doses of D-psicose at 5g (around 1/15 of carbohydrate intake) would be the minimum effective dose for suppressing the summit of plasma glucose and insulin concentration for 75g maltodextrin. This study confirmed the improving effects of glucose tolerance. D-psicose is expected to serve as a food material with depression glycemic index.

Another written report demonstrated that D-psicose inhibits abdominal sucrase and maltase activities in an uncompetitive style and suppress the plasma glucose increment after sucrose and maltose ingestion. Thus D-psicose may be useful in preventing postprandial hyperglycemia in diabetic patient when food containing sucrose and maltose are ingested (Lida et al. 2008).

Xylitol

Xylitol (Fig.1i) is a naturally occurring sugar. Xylitol is a five carbon carbohydrate that tastes and looks exactly like sugar.

Synthesis

The synthesis of xylitol from natural production is based on the pentosans occurring in many plants. Xylan, a constituent of pentosan, is a polysaccharide that can be hydrolyzed in to D-xylose. Xylitol can be synthesized by hydrogenation of xylose (Zakaria 2001). Xylitol also can be produced from D-glucose by three steps (Povelainen and Miasnikov 2006). Xylitol production from yeast is an alternative to chemical studies (Lachke and Jeffries 1986).

Metabolism and health attribute

Xylitol metabolises easily and independently from insulin in humans and produces very low amount energy. Xylitol has a recognized glycemic index of viii and accept a caloric value of two.4 calories/gm. (Sellman 2003)

Xylitol is non-fermentable and therefore cannot exist converted to acids past oral bacteria, thus it helps to restore a proper alkali metal/acid balance in mouth. Several clinical trials have indicated that xylitol products (chewing gum) are more effective in reducing dental caries.

In 1996, the joint adept committee on Food Additive (JECFA) confirmed the safety of xylitol for human consumption and allocated xylitol an ADI of 'Not specified'. The scientific committee for nutrient of the European Marriage (Eu) also determined xylitol 'adequate' for dietary uses (Xylitol 2009).

Tagatose

The ketohexose D-tagatose (Fig.1j) is structurally similar to D-fructose except for an inverted optically active heart. Because of its excellent gustatory modality and bulk properties, combined with a peradventure very depression free energy value, D-tagatose has potential for use equally a sweetener (Livesey and Brown 1996; Szepesi and Michaelis 1986).

Synthesis

D-tagatose is produced from lactose in two-step. Firstly, lactose is converted to glucose and galactose past hydrolysis and so galactose is isomerizd to D-tagatose by calculation calcium hydroxide (Calorie command council 2007).

Metabolism and health attribute

The metabolism of tagatose is identical as fructose simply it is incompletely absorbed. The report on small-scale-bowel absorption of tagatose concludes that 15g tagatose/day had a high apparent assimilation in the pocket-sized intestine of humans (Normen et al. 2001). The major part of ingested tagatose is fermented in the colon by ethnic microflora, resulting in the production of curt chain fat acrid. The short chain fatty acids are absorbed almost completely and metabolized.

Thus it can be ended that D-tagatose a carbohydrate with physiological properties potentially valuable for the control of both torso weight and symptoms of the metabolic syndrome as seen in diabetics (Livesey and Brown 1996).

Substances such every bit glucose and especially fructose that promote lopogenesis (Szepesi and Michaelis 1986) and have high glycosylation indices(Mc Phearson et al. 1988) could be replaced with D-tagatose with lower fat aggregating (Levin et al. 1995), lower glycosylation index (Bunn and Higgins 1994) and strong antidiabetic furnishings founds in rats (Szepsi 1996).

D-allose

D-allose (Fig.1k), a cis-aldohexose is a not caloric sweetening and bulking amanuensis which accept skilful antioxidant backdrop. The mass production of D-allose mainly accomplished from D-psicose in a batch reaction by crude recombinant L-rhamnose isomerase cross linked with gluteraldehyde (Menavuvu et al. 2006). Studies on D-allose supplementation on Dahl salt sensitive hypertensive rats and spontaneously hypertensive rats suggests the possibility of D-allose supplementation for prevention of table salt sensitive hypertension. D-allose has been reported to inhibit segmented neutrophil production and lower platelet count in vivo without other pregnant detrimental clinical effects in rats (Arnold and Silady 1997). D-allose is also used as potential inhibitor of various glycosides.

Other sweetener

Tableii summarizes the information about some nutritive sweetener known as sugar alcohol. They are highly soluble and non hygroscopic. The sugar alcohols are not-reducing, temperature stable and more than resistant to browning reactions than sucrose (Godshall 2007).

Tabular array 2

Properties of nutritive sweeteners

Sweetener	Sweetness	Cal/thousand	GI*	Blazon	Source
Erythritol	0.7	0.ii	0	Sugar booze	Fermentation of glucose past Moniliella pollinis, a fungus
Glucose	0.v	4.0	100	Monosaccharide	Hydrolyzed starch
Fructose	1.5–1.eight	4.0	19–23	Monosaccharide	Enzymatically isomerized glucose
HF CS	1–1.ii	4.0	60–65	Mixed glc/fru	Hydrolysis of corn starch and isomerization of glucose
HSH	0.five–0.7	2–4	varies	Mixed polyols	Hydrogenated partially hydrolyzed starch
Isomalt/Isomaltitol/Palatinit ™	0.45–0.65	ii.0	2	Sugar alcohol	Hydrogenated isomaltulose; equal mixture of gluco-sorbitol and gluco-mannitol
somaltulose/Palatinose ™	0.3–0.4	2.0	32	Disaccharide	Enzymatic isomerization of sucrose with Protoaminobacter rubrum; GRAS March 2006; a sucrose isomer
Lactitol	0.35–0.4	2.4	6	Saccharide booze	Hydrogenated lactose
Lactose	0.2–0.4	4.0	46	Disaccharide	Milk sugar
Lactulose	0.6	0.two	0	Disaccharide	Alkaline metal isomerization of lactose when milk is heated; prebiotic
Leucrose	0.5	2.0		Disaccharide	Dextransucrase action on sucrose and fructose; dextran by- product; a sucrose isomer
Maltitol	0.5–0.9	3.0	35–52	Sugar alcohol	Catalytic hydrogenation of high maltose corn syrup
Maltose	0.iv	four.0	105	Disaccharide	Enzymatic hydrolysis of starch; long time use
Maltulose	0.3–0.42			Disaccharide	Alkali metal isomerization of maltose; a sucrose isomer; footling used
Mannitol	0.5–0.72	i.six	0	Carbohydrate alcohol	Hydrogenation of invert or fructose; new fermentation process
Sorbitol	0.6	2.vi	9	Sugar alcohol	Hydrogenated glucose
Sucrose	1.0	4.0	61–65	Disaccharide	Pikestaff and beet
Tagatose	0.92	1.v	0	Galactose isomer	Hydrolyzed lactose; galactose converted past brine; GRAS 2001
Trehalose	0.5–0.7	3.6	45–50	Disaccharide	Patented 2-enzyme process from corn starch; GRAS 2000
Trehalulose	0.5–0.seven			Disaccharide	Sucrose isomer; by-product of palatinose production
Xylitol	one.0	three.0	7–13	Sugar alcohol	Hydrogenated xylose

Erythritol and other polyols

Erythritol is four carbon sugar booze (or polyol). It is manufactured by fermentation from glucose and sucrose by Trichosporonoides megachiliensis. It has a sweetness approximately 60–lxxx% of sucrose. Polyols are depression digestible carbohydrates which are poorly absorbed from the small intestine. These are besides used for their humectant and bulking backdrop. Excessive consumption has a laxative effect due to unabsorbed polyol increasing the osmotic potential of the gut lumen and other gastrointestinal outcome. Erythritol is considered to be of depression toxicity. It has been assessed by JECFA which assigned it an 'ADI not specified'. Studies with human accept shown them that ingested doses of erythritol is captivated from the small intestine and excreted in the urine unchanged (Munro et al. 1998). Another polyol similar sorbitol show belongings close to sugar (Chetana et al. 2010).

Trehalose

Trehalose is a non-reducing disaccharide that consists of two glucose units linked by a 1,i-glycosidic bond. It is with a relative sugariness of 40–45% that of sucrose. Trehalose is produced directly from nutrient-class starch past a multienzymatic process. This disaccharide is enzymatically hydrolyzed past the enzyme trehalase in the pocket-size intestine in to 2 glucose subunits which are afterward absorbed and metabolized in a manner similar to maltose. Present study reports that adding trehalose to dehydrated pear cubes could improve aroma retention by 15% (Komes et al. 2006). It has also added advantage of being an antioxidant.

Several safety studies on trehalose have been evaluated by JECFA, 2001 and allocated an ADI of 'non specified'. Trehalose is canonical in Japan, Korea, Taiwan, and Great britain (Kidd and Devorak 1994).

Stevia rebaudiana

Stevia is a natural herb. This nothing calorie sweetener mainly containing steviol glycoside which is 10–15 times sweeter than sucrose. Man body does non metabolize these sweet glycosides, and then obtains no-calories from stevia. Unlike artificial sweetener, the sweet glycoside does non interruption down in heat which makes stevia an fantabulous sweetener for cooking and baking. Studies have indicated that stevia tends to lower the elevated blood pressure. It too significantly improves nutritional status of diabetic patients (Kochhar et al. 2008).

Conclusion

The number of people suffering from diabetes, obesity, hypertension, and heart illness is increasing every year. Increasing amounts of sugars in nutrient, sweets, soft drinks and and so on have raised some concern about their health effects. So nowadays artificial sweetener are receiving much more attention. But information technology gets bad reputation due to their prophylactic issue. On the other paw in spite of demand for rare sugars, their commercial availability, application and usefulness is negligible equally they are expensive to prepare and unavailable in nature. So research is required to make natural sugars having the desired quantities of sweetness, low caloric value, and least observed physiological furnishings.

Acknowledgement

The research work is financially supported past the Centre for Advanced studies (CAS I) programme under University Grants Commission (UGC), Govt. of India and Dept. of Food Processing Industries & Horticulture, Govt. of West Bengal, Bharat, Some facilities have been provided by the centre for Medicinal Food & Applied Nutrition of Jadavpur University, Bharat.

References

• [ADA] American Dietetic Association, Position of the American Dietetic Clan: use of nutritive and nonnutritive sweeteners. J Am Diet Assoc. 2004;104:255–275. doi: x.1016/j.jada.2003.12.001. [PubMed] [CrossRef] [Google Scholar]
• Ager DJ, Pantaleone DP, Henderson SA, Katritzky AR, Prakash I, Walters DE. Commercial, Constructed Nonnutritive Sweeteners. Angew Chem Int Edit. 1998;37:1802–1817. doi: 10.1002/(SICI)1521-3773(19980803)37:13/14<1802::AID-ANIE1802>3.0.CO;ii-9. [CrossRef] [Google Scholar]
• Arnold E C, Silady P J (1997) Use of D-allose as an immunosuppressive agent. Patentgenious United states Patent 5620960. http://www.patentgenius.com/patent/5620960.html. Accessed five March 2010
• Arora Southward, Singh VP, Sharma Five, Wadhwa BK, George 5, Singh AK, Sharma GS. Analysis of sucralose and its storage stability in barfi. J Food Sci Technol. 2009;46:114–117. [Google Scholar]
• Bennett C, Dordick JS, Hacking AJ, Cheetham PSJ. Biocatalytic synthesis of disaccharide high-intensity sweetener sucralose via a tetrachlororaffinose intermediate. Biotechnol Bioeng. 1992;39:211–217. doi: 10.1002/bit.260390213. [PubMed] [CrossRef] [Google Scholar]
• Bilik V, Tihlarik Chiliad. Reaction of Saccharides catalyzed by molybdate ions. Epimerization of ketohexoses. Chem Zvesti. 1973;28:106–109. [Google Scholar]
• Bopp BA, Sonders RC, Kesterson JW. Toxicological aspects of cyclamate and cyclohexylamine. Crit Rev Toxicol. 1986;xvi:213–306. doi: 10.3109/10408448609037465. [PubMed] [CrossRef] [Google Scholar]
• Bunn HF, Higgins PL. Reactions of monosaccharides with proteins- possible evolutionary significances. Science. 1994;213:222–224. doi: ten.1126/science.12192669. [PubMed] [CrossRef] [Google Scholar]
• Beyts P K, Lillard D W, Batterman C 1000 (1995) A sucralose compositon. Patentstrom United states patent 5380541. http://www.patentstorm.united states of america/patents/5380541/fulltext.html. Accessed 21 August 2009
• Calorie control Council (2007) http://www.caloriecontrol.org/tagatose.html. Accessed 12 February 2009
• Chetana R, Ravi R, Yella Reddy S. Effect of processing variables on quality of milk burfi prepared with and without sugar. J Food Sci Technol. 2010;47:114–118. doi: 10.1007/s13197-010-0005-5. [PMC costless article] [PubMed] [CrossRef] [Google Scholar]
• Clauss Thousand, Jensen H. Cycloadditionen von halogensulfonylisocyanaten an acetylene. Tetrahedron Lett. 1970;11:119–122. doi: 10.1016/S0040-4039(01)97654-3. [CrossRef] [Google Scholar]
• Clauss J, Schmidt RK, Spiess HW. Determination of domain sizes in heterogeneous polymers by solid-land NMR. Acta Polym. 1993;44:1–17. doi: 10.1002/actp.1993.010440101. [CrossRef] [Google Scholar]
• Doner LW. Isomerization of D-fructose by base of operations - lequid-cromatographic evaluation and the isolation of D-psicose. Carbohyd Res. 1979;70:209–216. doi: 10.1016/S0008-6215(00)87101-3. [CrossRef] [Google Scholar]
• Drasar BS, Renwick AG, Williams RT. The role of the gut flora in the metabolism of cyclamate. Biochem J. 1972;129:881–890. [PMC free article] [PubMed] [Google Scholar]
• [FDA] Food and Drug Administration (2006) Nutrient labeling: health claims; dietary noncariogenic sugar sweeteners and dental caries. Fed Reg 71:15559–15564 http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?position=all&folio=15559&dbname=2006_register. Accessed ten June 2010 [PubMed]
• George V, Arora S, Wadhwa BK, Singh AK. Analysis of multiple sweeteners and their deposition products in lassi by HPLC and HPTLC plates. J Food Sci Technol. 2010;47:408–413. doi: ten.1007/s13197-010-0067-4. [PMC complimentary commodity] [PubMed] [CrossRef] [Google Scholar]
• Godshall MA. The Expanding World of Nutritive and Non-Nutritive Sweeteners. Sugar J. 2007;69:12–20. [Google Scholar]
• Green GM, Perlin Every bit. O-Isopropylidene derivatives of D-allose (D-psicose) and D-erythro-hexopyranose-2,3-dilulose. Can J Biochem Cell B. 1968;46:765–770. doi: 10.1139/o68-117. [PubMed] [CrossRef] [Google Scholar]
• Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med. 2004;fifty:145–149. [PubMed] [Google Scholar]
• Hill J B, Gelman Y, Dryden Jr HL, Erickson R, Hsu Yard, Johnson MR (1991) I-pot process for the preparation of α-L-aspartyl-L-phenylalanine methyl ester hydrochloride. JustiaPatents United states of america Patent 5053532. http://patents.justia.com/1991/05053532.html. Accessed xv June 2010
• Horne J, Lawless HT, Speirs Due west, Sposato D. Bitter taste of saccharin and acesulfame- K. Chem Senses. 2002;31:8–27. [PubMed] [Google Scholar]
• Izumori K. Bioproduction strategy for rare hexose sugars. Naturwissenschaften. 2002;89:120–124. doi: 10.1007/s00114-002-0297-z. [PubMed] [CrossRef] [Google Scholar]
• [JFECFA] Joint FAO/WHO Proficient Committee on Nutrient Additives (2004) Sixty-third meeting eight to 17 June. Geneva WHO. http://www.who.int/ipcs/publications/ jecfa/en/Summary63final.pdf. Accessed 3 January 2006
• Kim HJ, Hyun EK, Kim YS, Lee YJ, Oh DK. Label of an Agrobacterium Tumifaciens D-psicose 3-epimerase that converts D-fructose to D-psicose. Appl Environ Microbiol. 2006;72:981–985. doi: 10.1128/AEM.72.2.981-985.2006. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
• Komes D, Lovric T, Ganic KK. Scent of dehydrated pear products. Food Sci Technol. 2006;xl:1578–1586. [Google Scholar]
• Kochhar A, Dhindsa S, Sachdeva R. Consequence of Stevia Foliage (Stevia rebaudiana) Pulverisation Supplementation and Nutrition Counselling on Anthropometric Parameters and Gain in Knowledge of the Subjects. Ethno-Med. 2008;2:107–113. [Google Scholar]
• Kroger M, Meister Thousand, Kava R. Low-calorie Sweeteners and Other Saccharide Substitutes: A Review of the Rubber Issues. Compr Rev Nutrient Sci F. 2006;5:35–47. doi: 10.1111/j.1541-4337.2006.tb00081.x. [CrossRef] [Google Scholar]
• Kidd G, Devorak J. Trehalose is a sweet target for agrobiotech. Biotechnol. 1994;12:1328–1329. doi: ten.1038/nbt1294-1328. [CrossRef] [Google Scholar]
• Knight I. The development and applications of sucralose, a new high-intensity sweetener. Can J Physiol Pharmacol. 1993;72:435–439. doi: x.1139/y94-063. [PubMed] [CrossRef] [Google Scholar]
• Lachke AH, Jeffries TW. Levels of the enzymes of the pentose phosphate pathway in Pachysolen tannophilus Y-2460 and selected mutants. Enzyme Microb Technol. 1986;8:353–359. doi: 10.1016/0141-0229(86)90135-3. [CrossRef] [Google Scholar]
• Levin GV, Zehner LR, Saunders JP, Beadle IR. Sugar substitutes, their energy values, bulk characteristics and potential health benefits. Am J Clin Nutr. 1995;62:1161–1168. [PubMed] [Google Scholar]
• Lida T, Kishimoto Y, Yoshikawa Y, Hayashi Northward, Okuma Chiliad, Tohi Yard, Yagi One thousand, Matsuo T, Izumori K. Acute D-psicose Assistants Decreases the Glycemic Responses to an Oral Maltodextrin Tolerence Test in Normal Adults. J Nutr Sci Vitaminol. 2008;54:511–524. doi: x.3177/jnsv.54.511. [PubMed] [CrossRef] [Google Scholar]
• Livesey G, Dark-brown JC. D-Tagatose Is a Bulk Sweetener with Zero Energy Determined in Rats. J Nutr. 1996;126:1601–1609. [PubMed] [Google Scholar]
• Magnuson BA, Burdock GA, Doull J. Aspartame: a safety evaluation based on electric current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol. 2007;37:629–727. doi: x.1080/10408440701516184. [PubMed] [CrossRef] [Google Scholar]
• Matsuo T, Izumori Grand. D-psicose inhibits abdominal α-glucosidase and suppresses glycemic response later on sugar ingestion in rats. Tech Bull Fac Agr, Kagawa Univ. 2006;58:27–32. [Google Scholar]
• Matsuo T. Inhibitary effects of D-psicose on glycemic responses later oral carbohydrate tolerance test in rats. J Jpn Soc Nutr Food Sci. 2006;59:247–253. doi: 10.4327/jsnfs.59.119. [CrossRef] [Google Scholar]
• Mazur RH, Goldkamp AH, James PA, Schlatter JM. Structure-gustatory modality relationships of aspartic acid amides. J Med Chem. 1970;6:1217–1221. doi: 10.1021/jm00300a046. [PubMed] [CrossRef] [Google Scholar]
• Mazur RH, Ripper A. Peptide-based sweeteners. London: Engineering Publishers; 1979. [Google Scholar]
• Mc Phearson JD, Shilton BH, Walton DJ. Role of fructose in glycosylation and cantankerous-linking of proteins. Biochemistry-US. 1988;27:1901–1907. doi: 10.1021/bi00406a016. [PubMed] [CrossRef] [Google Scholar]
• Menavuvu BT, Poonperm W, Leang K, Noguchi N, Okada H, Morimoto Thousand, Granstrom TB, Takada G, Izumori Thousand. Efficient biosynthesis of D-allose from D-psicose by cross- linked recombinant Fifty-rhamnose Isomerase: Separation of product by ethanol crystallization. J Biosci Bioeng. 2006;101:340–345. doi: 10.1263/jbb.101.340. [PubMed] [CrossRef] [Google Scholar]
• Munro IC, Berndt WO, Borzelleca JF, Flamm 1000, Lynch BS, Kennepohl E, Bar EA, Modderman J. Erythritol: An interpretive summary of biochemical, metabolic, toxicological and clinical data. Nutrient Chem Toxicol. 1998;36:1139–1174. doi: x.1016/S0278-6915(98)00091-X. [PubMed] [CrossRef] [Google Scholar]
• Nabors LO. Sweet choices: saccharide replacements for foods and beverages. Food Technol. 2002;56:28–32. [Google Scholar]
• Normen L, Laerke HN, Jensen BB, Langkilde AM, Andersson H. Small-bowel absorption of D-tagatose and related effects on saccharide digestibility: an ileostomy study. Am J Clin Nutr. 2001;73:105–110. [PubMed] [Google Scholar]
• [NTP] Natl Toxicology Programme (2005) NTP report on the toxicology studies of aspartame in genetically modified (FVB Tg.Air-conditioning hemizygous) and B6.129- Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129- Trp53tm1Brd (N5) haploinsufficient] mice. October NIH Pub No. 06–4459. http://ntp.niehs.nih.gov/files/ GMM2_Web.pdf. Accessed 9 February 2006 [PMC free article] [PubMed]
• Neotame: Stability overview (2002) http://www.neotame.com/pdf/neotame_stability_overview_US.pdf. Accessed 27 February 2009
• Patel RM, Sharma R, Grimsley Eastward. Popular Sweetener Sucralose as a Migraine Trigger. J Caput Face Pain. 2006;46:1303–1304. doi: 10.1111/j.1526-4610.2006.00543_1.x. [PubMed] [CrossRef] [Google Scholar]
• Peter J A, Walker R, Leclercq C (2002) Alitame. WHO Food Additives Serial. http://www.inchem.org/documents/jecfa/jecmono/v50je02.htm. Accessed 6 March 2009
• Povelainen G, Miasnikov AN. Production of xylitol by metabolically engineered strains of Bacillus subtilis. J Biotechnol. 2006;128:24–31. doi: ten.1016/j.jbiotec.2006.09.008. [PubMed] [CrossRef] [Google Scholar]
• Prakash I (2007) Synthesis of Northward-[Due north-(3,3-dimethylbutyl)-L-α-aspartyl]-50-phenylalanine i-methyl ester using 3,3-dimethylbutyraldehyde precursors. Ip.com US Patent 7288670. http://ip.com/patent/US7288670. Accessed 2 June 2010
• Prakash I, Corliss G, Ponakala R, Ishikawa G. Neotame: the next-generation sweetener. Food Technol. 2002;56:36–40. [Google Scholar]
• Prakash I, Zhao R Y (2001) Chemoenzymatic synthesis of neotame, Pub No. WO/2001/085977. http://world wide web.wipo.int/pctdb/en/wo.jsp?wo=2001085977. Accessed 6 March 2009
• Priebem PM, Kauffman GB. Making governmental policy under weather of scientific uncertainty: A century of controversy well-nigh saccharin in congress and the laboratory. Minerva. 1980;18:556–574. doi: 10.1007/BF01096124. [PubMed] [CrossRef] [Google Scholar]
• Renwick AG, Thompson JP, Shaughnessy Grand, Walter EJ. The metabolism of cyclamate to cyclohexylamine in humans during long-term administration. Toxicol Appl Pharmacol. 2004;196:367–80. doi: 10.1016/j.taap.2004.01.013. [PubMed] [CrossRef] [Google Scholar]
• Rymon Lipinski GW. Sensory Properties of Acesulfame-K. New York: Marcel Dekker; 1991. [Google Scholar]
• [SCF] Scientific Committee on Food (2000) Revised stance of the Scientific Committee on Food on cyclamic acid and its sodium and calcium salts http://ec.europa.european union/food/fs/sc/scf/out53_en.pdf. Accessed five May 2000
• Scott SK, Rabito F, Price PD, Butler NN, Schwartzbaum JA, Jackson BM, Love RL, Harris RE. Comorbidity among the morbidity obese: a comparative study of 2002 U.Due south hospital patient discharge. Surg Obes Relat Dis. 2006;2:105–111. doi: 10.1016/j.soard.2006.01.004. [PubMed] [CrossRef] [Google Scholar]
• Serdula MK, Mokdad AH, Williamson DF, Galuska DA, Mendlein JM, Heath GW. Prevalence of attempting weight loss and strategies for controlling weight. J Am Med Assoc. 1999;282:1353–1358. doi: 10.1001/jama.282.xiv.1353. [PubMed] [CrossRef] [Google Scholar]
• Sellman S (2003) Xylitol: Our Sugariness Salvation? Nexus New Times: January-February http://www.lib .umich.edu/dentlib/nihcdc/abstracts/hayes.html. Accessed sixteen March 2009
• Sorensen LB, Mella P, Flint A, Martens Yard, Raben A. Issue of sensory perception of nutrient in appetite and food intake. A review of studies on humans. Int J Obes. 2003;27:1152–1166. doi: ten.1038/sj.ijo.0802391. [PubMed] [CrossRef] [Google Scholar]
• Sun Y, Hayakawa Southward, Jiang H, Ogawa M, Izumori K. Rheological characteristics of oestrus-induced custard pudding gels with high antioxidative activity. Biosci Biotech Biochem. 2006;70:2859–2867. doi: ten.1271/bbb.60256. [PubMed] [CrossRef] [Google Scholar]
• Sunday Y, Hayakawa S, Ogawa M, Izumori One thousand. Antioxidant properties of custard pudding dessert containing rare hexose, D-psicose. Food Command. 2007;18:220–227. doi: 10.1016/j.foodcont.2005.09.019. [CrossRef] [Google Scholar]
• Sun Y, Hayakawa Southward, Ogawa M, Fukada G, Izumori Thousand. Influence of a Rare Sugar, d-Psicose, on the Physicochemical and Functional Backdrop of an Aerated Nutrient Organization Containing Egg Albumen. J Agricult Food Chem. 2008;56:4789–4796. doi: 10.1021/jf800050d. [PubMed] [CrossRef] [Google Scholar]
• Szepesi B, Michaelis OE. Disaccharide effect - comparison of metabolic effects of the intake of disaccharide and of their monosaccharide equivalents. In: Macdonald I, Vrana A, editors. Metabolic Effects of Dietary Carbohydrates. 4. Switzerland: Karger S Basel; 1986. pp. 192–219. [PubMed] [Google Scholar]
• Szepsi B. Carbohydrates. Washington: ILSI Press; 1996. [Google Scholar]
• Tarbell DS, Tarbell AT. The discovery of saccharin. J Chem Educ. 1978;55:161–162. doi: ten.1021/ed055p161. [CrossRef] [Google Scholar]
• Takeshita Thou, Suga A, Takada G, Izumori G. Mass product of D- psicose from D-fructose by a continuous bioreaction organization using immobilized D-tagatose 3 epimerage. J Biosci Bioeng. 2002;90:453–455. [PubMed] [Google Scholar]
• Trocho C, Pardo R, Rafecas I, Virgili JX, Remesar X, Fernandez-Lopez JA, Alemany M. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci. 1998;63:337–349. doi: 10.1016/S0024-3205(98)00282-3. [PubMed] [CrossRef] [Google Scholar]
• [USFDA] US Food and Drug Administration (2003) Nutrient additives permitted for straight improver to food for human consumption; acesulfame potassium Last rule. FedReg 68:75411–75413.http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?position=all&page=75411&dbname=2003_register. Accessed 22 May 2006 [PubMed]
• [USFDA] United states Food and Drug Administration (2002) Food additives permitted for direct improver to food for human being consumption;Neotame. Fed Reg 67:45300–45310 http://frwebgate.access.gpo.gov/cgi-bin/getpage.cgi?position=all&page=45300&dbname=2002_register. Accessed 22 May 2006 [PubMed]
• [USFDA] US Food and Drug Administration (1999) Food additives permitted for direct addition to food for human consumption: sucralose. Fed Reg 64:43908–43909. http://www.fda.gov/ohrms/dockets/98fr/081299b.txt. Accessed vii March 2009
• Weihrauch MR, Diehl V. Artificial sweeteners - do they bear a carcinogenic hazard. Ann Oncol. 2004;xv:1460–1465. doi: x.1093/annonc/mdh256. [PubMed] [CrossRef] [Google Scholar]
• Wong CH, Whitesides GM. Enzymes in Synthetic Organic Chemical science. Oxford: Elsevier; 1994. [Google Scholar]
• Xylitol (2009) Polyols information sourace. http://www.polyol.org/fap/fap_xylitol.html. Accessed 5 Feb 2009
• Zakaria A. Production of natural and rare pentoses using microorganisms and their enzymes. Electron J Biotechnol. 2001;four:103–111. [Google Scholar]

---

Articles from Journal of Food Science and Technology are provided here courtesy of Springer

---

dingeraffiriplent.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982014/

Share this post